StockNews.AI
WBA
StockNews.AI
197 days

Rosen Law Firm Urges Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

1. Rosen Law Firm announces a class action against WBA shareholders. 2. The lawsuit claims WBA misled investors about business operations. 3. Allegations include violations of federal law regarding prescriptions. 4. Potential regulatory scrutiny and reputational harm faced by WBA. 5. Shareholders can participate in the class action by March 31.

9m saved
Insight
Article

FAQ

Why Bearish?

Involvement in a class action lawsuit usually negatively impacts stock prices. Past examples show stock dips during similar legal challenges.

How important is it?

Legal issues significantly impact investor confidence and stock performance. With significant shareholder losses declared, attention is drawn to WBA's operational integrity.

Why Short Term?

The class action is immediate, impacting short-term investor sentiment. Legal challenges can quickly influence stock prices.

Related Companies

Rosen Law Firm Urges Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--()--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers and acquirers of common stock of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) between April 2, 2020 and January 16, 2025, both dates inclusive (the “Class Period”). The lawsuit states that Walgreens “operates as a healthcare, pharmacy, and retail company” in the U.S., and internationally.

For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.

The Allegations: Rosen Law Firm is Investigating the Allegations that Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Misled Investors Regarding its Business Operations.

According to the lawsuit, defendants, throughout the Class Period, failed to disclose to investors that: (1) contrary to Walgreens’ purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement of the same; (2) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (3) Walgreens’ revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (4) as a result, Walgreens’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

What Now: You may be eligible to participate in the class action against Walgreens. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by March 31, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

Related News